Construction of an epitope-tagged clone of GRA3 for electroporation into Toxoplasma Gondii by Strachan, Dina D.
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
1994
Construction of an epitope-tagged clone of GRA3
for electroporation into Toxoplasma Gondii
Dina D. Strachan
Yale University
Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Strachan, Dina D., "Construction of an epitope-tagged clone of GRA3 for electroporation into Toxoplasma Gondii" (1994). Yale
Medicine Thesis Digital Library. 3215.
http://elischolar.library.yale.edu/ymtdl/3215
VALE UNIVERSITY LIBRARY 
N%H i ;ttdp£i i 
tPWPpJWWilTO :{ox%!,#^;epv'wj: 
' ■ . fYfhHy/dlV'>'\" 
VMtyW'X i•''; Duis ;pi'.StfebjiotH .pv > :{> ■■, • v\!v XS-’■■'>;; 
,; . -;-v(/' > \;->• vv..:'.-;; v v</i>J\>v‘A-i -.'■■;:v w.x .;/ -\.)\; -?v< & ^v-o. 5 % i 
/. 'i v:--:\.< V 'i< )v!)Vv;!: ;•' V^>'CVKS4 H’lt’OV' ‘44^^^ - x 
•\ • :' '>.x-\ :. H r \ \/1’\‘ /•;; ■y, \ fe^.1 '. N\;v, 
, > \\ / .\:: ' * . »s / : ’ y v x, y ■ j fx. I<41** \/J.} J ,: rS y"//v« } ' >\ 
s'^ \Xp,' ■ \ X X X' v /'.X y.. V {"‘y ' / 'X /X'V>) v.1 ' |; 
- ■ ;■ ' ■ ' 4 4; Yale; U i, I wi'aity K\fi>k ::-4U4^v4S1vS||4. 
•
X/
. •
 
HARVEY CUSHING / JOHN HAY WHITNEY 
MEDICAL LIBRARY 
MANUSCRIPT THESES 
Unpublished theses submitted for the Master's and Doctor's degrees and 
deposited in the Medical Library are to be used only with due regard to the 
rights of the authors. Bibliographical references may be noted, but passages 
must not be copied without permission of the authors, and without proper credit 
being given in subsequent written or published work. 
This thesis by has been 
used by the following persons, whose signatures attest their acceptance of the 
above restrictions. 
NAME AND ADDRESS DATE 

Digitized by the Internet Archive 
in 2017 with funding from 
The National Endowment for the Humanities and the Arcadia Fund 
https://archive.org/details/constructionofepOOstra 


CONSTRUCTION OF AN EPITOPE-TAGGED CLONE OF GRA3 FOR 
ELECTROPORATION INTO TOXOPLASMA GONDII 
A Thesis Submitted to the Yale University School of Medicine in Partial Fulfillment of 
the Requirements for the Degree Doctor of Medicine 
by 
Dina D. Strachan 
class of 1994 
UL13 1335 
Table Contents 
Abstract 1 
Introduction 2 
Experimental Methods and Design 13 
Results 25 
Discussion 27 
References 32 

CONSTRUCTION OF AN EPITOPE-TAGGED CLONE OF GRA3 FOR 
ELECTROPORATION INTO TOXOPLASMA GONDII. Dina D. Strachan (Sponsored 
by Keith A. Joiner) Section of Infectious diseases. Department of Internal Medicine, Yale 
University, School of Medicine, New Haven, CT. 
Abstract 
GRA3 is a protein produced and secreted by the intracellular, apicocomplexan 
parasite Toxoplasma gondii. The parasite enters nucleated cells in a parasite-directed 
process which involves the formation of a parasitophorous vacuole (PV). Upon entry the 
membrane of this vacuole, the parasitophorous vacuole membrane (PVM) is devoid of 
intramembranous particles. Sometime after invasion, GRA3 appears associated with the 
PVM. The amount of GRA3 associated with the PVM increases as the membrane matures. 
It is thought that GRA3 may be involved in the intracellular survival of the parasite. 
Exploration into the topology of this protein with respect to the PVM may provide insight 
into the GRA3's role in intracellular survival. Construction of an epitope-tagged cDNA 
clone of GRA3 was attempted without success. Construction of an epitope-tagged 
genomic clone of GRA3 from a X-DASHII phage library is proposed. Further 
experiments involving the electroporation of a plasmid carrying an epitope-tagged clone 
into Toxoplasma gondii are planned. 
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I) Introduction 
A) Obligate intracellular parasites 
Parasitism can be generally defined as the use of one organism by another as a 
source of food and reproductive energy. A parasite differs from a predator in that it does 
not require the immediate death of the exploited organism. Most commonly, parasites are 
much smaller than their hosts. This size difference opens up additional opportunities for 
parasites which are unavailable to predators. Intracellular parasites have evolved the 
capability to exploit the unique set of resources available by taking up residence inside of 
another cell. Adapting to intracellular life is not, however, without its challenges. Firstly, 
for a relationship of intracellular parasitism to be established, the parasite may have to 
acquire an adaptation which facilitates its entry into the host cell. Once inside the cell, the 
parasite is then faced with the task of avoiding destruction and the challenge of co-opting or 
redirecting the host cell's functions toward its own survival and reproduction. Unlike 
facultative intracellular parasites, which have maintained their ability to survive both inside 
and outside the host cell, obligate intracellular parasites, such as Toxoplasma gondii, have 
adapted so well to intracellular living that they can no longer survive and reproduce in the 
extracellular environment. 
B) Conventional Mechanisms of Cell Entry 
An intracellular parasite must, of course, enter a cell. Cell entry presents the 
challenge of crossing the plasma membrane. Small molecules may be transported directly 
into the cytoplasm of a target cell via a carrier protein located in that cell's plasma 
membrane. Instead of actually crossing the membrane, a number of enveloped viruses 
(e.g. HIV) gain direct access to the cytoplasm through the fusion of the viral envelope to 
the plasma membrane of the target cell (Kielian, 1990). By far, however, the most 
common mechanism of cell entry for macromolecules and other particles, is through 
processes involving the invagination of the plasma membrane and the formation of 
vesicles. 
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There are several known mechanisms by which cells take up foreign material into 
membrane-bound vesicles. These processes may operate for the internalization of inert 
substances, such as latex beads, as well as for complex organisms. They differ with 
respect to a number of features, including cell type involved, particle size, and sorting of 
the vesicular contents. Endocytosis is a term that was proposed in 1963 to include 
processes such as phagocytosis ("cell eating") and pinocytosis ("cell drinking") (Bo Van 
Dews, 1989). Currently, however, endocytosis is often used synonymously with 
pinocytosis (although a distinction is sometimes made with respect to vesicle size); 
phagocytosis has been shown to be a distinct process. 
Endocytosis 
Endocytosis is a constitutive, or on-going, process which can be carried out by all 
eukaryotic cells. This mechanism of internalization can be divided into clathrin-dependent 
and clathrin-independent categories-both to be discussed. Clathrin-dependent endocytosis 
begins at a specialized area of plasma membrane, the coated pit, so named because it is an 
invagination to which clathrin, a structural protein, localizes (Mahaffey, 1989). Clathrin is 
probably linked to the plasma membrane, and to the cytoplasmic tails of membrane 
receptors, through proteins called adaptins (Pearse, 1988; Rodman, 1990). Assembly and 
attachment of the clathrin coat is followed by further invagination and the formation of the 
coated vesicle (Lin, 1991; Brodsky, 1988; Fine and Ockleford, 1984). Both fluid-phase 
and receptor-bound material may be internalized in the process. Soon after the formation of 
the vesicle, the clathrin coat is shed (Salzman, 1988). At this time, the vesicle is termed an 
endosome. The shed clathrin is recycled to the plasma membrane (reviewed in Pearse, 
1987). 
Receptor-mediated endocytosis (RME), like endocytosis in general, is a constitutive 
process. Uptake of ligand during receptor-mediated endocytosis, however, depends upon 
the localization of the receptor-ligand complex to the clathrin pit. A number of receptors. 
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such as the LDL and transferrin receptors, are clustered in the clathrin pit and are 
internalized regardless of whether they are bound to ligand (Brown and Goldstein, 1986). 
Other receptors, however, such as the epidermal growth factor (EGF) receptor, are 
distributed randomly on the cell surface and only localize to the clathrin pit to be 
endocytosed after binding with ligand (Brown, 1991). The signals for localization and 
internalization appear to be transmitted at the cytoplasmic tail of the receptor (reviewed in 
Pearse, 1987). The original evidence for this observation came from the finding that in a 
particular form of familial hypercholesterolemia the mutation resulting in the failure of 
internalization of the LDL receptor has been localized to the receptor's cytoplasmic tail 
(Davis, 1986b). Subsequently, a variety of coated pit localization signals most of which 
contain tyrosine, have been identified. Membrane proteins normally excluded from the pit 
(e.g. influenza virus hemagglutinin) have been induced to localize there after the addition 
of a tyrosine residue (Lazarovits, 1988). 
The possible fates of internalized material are many. The various ligands contained 
in a single endosome may have distinct fates. The pathway that a receptor-ligand complex 
takes is influenced by a number of factors, including function, cell type and distribution of 
receptors (reviewed in Brown, 1991). During the vesicle's maturation process, ATP- 
driven proton pumps in its membrane acidify the vesicular contents (Yamashiro, 1984). 
This drop in vesicular pH has been shown to play a significant role in the sorting of the 
vesicular contents (reviewed in Mellman, 1986). Most commonly, the contents of 
endosomes are passed into the lysosomal system where they are degraded. Other ligands, 
however, are able to escape degradation through transport back to the plasma membrane 
and release from the cell. Pathways of receptor-mediated endocytosis have been classified 
based on the sorting of the endosome's contents (reviewed in Brown et al., 1983; 
Goldstein et al., 1985; Mikhailov, 1989; Shepherd, 1989). 
The pathway of the LDL receptor, described by Brown and Goldstein in 1986, 
exemplifies a class of receptor-mediated endocytosis characterized by passage of the ligand 
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into the lysosomal pathway and recycling of the receptor (Brown and Goldstein, 1986). A 
drop in pH in the endosomal compartment results in the release of the ligand from the 
receptor. The receptor, which is membrane-bound, pinches off in a vesicle which returns 
to the plasma membrane. The released ligand, as well as the rest of the endosomal 
contents, enter the lysosomal pathway. 
Another type of RME is represented exclusively by the transferrin receptor. 
Transferrin is a plasma protein which binds iron and transport it to cells. In its iron- 
associated state, transferrin binds its receptor, which is located in the clathrin pit, and is 
internalized (Dautry-Varsat, 1983; Thorstensen, 1990; Aisen, 1992) In the acidic 
environment of the endosome (pH 5.5), the iron is unable to remain bound to transferrin 
and the iron is released into the lumen of the compartment (Dautry-Varsat, 1983). The 
association between the iron-free protein, now called apotransferrin, and its receptor is 
stable at acid pH (Dautry-Varsat, 1983; Aisen, 1992). The two remain associated and 
escape degradation via a smaller vesicle which buds off of the endosomal membrane. This 
vesicle is recycled to the plasma membrane where the neutral pH results in the release of 
apotransferrin from its receptor (Dautry-Varsat, 1983). 
Both receptor and ligand are degraded in the lysosomal pathway in a third type of 
receptor-mediated endocytosis. Ligands which follow this pathway (e.g. EGF) are usually 
involved in signal transduction (Brown, 1991). 
Transcytosis is a process unique to polarized cells. The receptor-ligand complex is 
transported across the cell to the membrane opposite to the site of entry (Brandli, 1991; 
reviewed in Rodman, 1990 ). The ligand is released, whereas the receptor may be recycled 
or degraded. This class is commonly represented by immunoglobulin-receptor complexes 
which are transported across epithelial cells (Mostov, 1991; Abrahamson, 1981; 
Rodewald, 1980). 
Clathrin-independent mechanisms of endocytosis have been identified (reviewed in 
van Deurs, 1989; Sandvig, 1991). Substances such as cholera toxin (Carpentier, 1989) 
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and ricin (Madshus, 1987) are known to be taken up in clathrin-independent processes. 
Vesicles involved in these alternative uptake processes may be naked or coated with a 
material other than clathrin as has been found in the collecting duct intercalated cells of the 
kidney (Brown, 1987). The most thoroughly studied structures involved in clathrin- 
independent processes are the caveolae, flask-shaped invaginations on the surface of many 
cells (Anderson, 1993; Anderson, 1992; Rohlich, 1976; Orci, 1978). These structures 
have been shown to have some endocytic function (Tran, 1987), however, as with the 
other clathrin-independent uptake pathways their role appears to be minor. Recent work by 
Hansen, et. al, however, has demonstrated that particles internalized in both types of 
endocytosis may have similar fates as Con A-gold taken up by a clathrin-independent 
mechanism was found to be delivered to endosomes containing transferrin (Hansen, 1993). 
Phagocytosis 
Phagocytosis, or "cell eating," is another major cellular uptake process. Generally 
speaking, phagocytosis is limited to "professional" phagocytes of the reticuloendothelial 
system. This group includes neutrophils, eosinophils, monocytes, and, most importantly, 
macrophages. The ability to engulf invading microorganisms allows these cells to play a 
critical role in the defense of the host against infection. Each cell type contains a distinct set 
of cytoplasmic granules which contain a variety of hydrolytic enzymes. These granules 
essentially function as lysosomes as fusion of the phagosome with the granules may result 
in the destruction of an engulfed organism. 
Phagocytosis, unlike endocytosis, is a receptor-dependent process. Receptors on 
the surface of the phagocytes bind to particles opsonized by antibodies (exposing the Fc 
portion), the C3b or iC3b component of complement, or containing oligosaccharide 
residues recognized by the mannose-fucose receptor (Stossel, 1978; reviewed in 
Silverstein, 1993). Internalization of a particle in phagocytosis involves the 
circumferential binding of receptors to these ligands on the target particle in a process called 
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"zippering." (Griffin, 1975). A major criterion of phagocytosis is that the ligands be 
distributed evenly over the surface of the particle being engulfed as particles expressing 
ligands at only one pole can bind to the target cell, however, they cannot be internalized 
(Griffin, et al, J. Exp. Med, 1975). 
Clathrin has been found to occasionally be present at the sites of initiation of 
phagocytosis (Aggeler, 1982), however, a number of findings, in addition to the 
"zippering" requirement, suggest that this process is distinct from endocytosis. 
Phagocytosis involves the mobilization of actin filaments, and unlike endocytosis, is 
inhibited by cytochalasin B (Aggeler, 1982; Stossel, 1978). In addition, the vesicles 
formed in phagocytosis, which are 1 pm or greater in diameter (Stossel, 1978), are 
consistently bigger than those formed in endocytosis which average about 150 nm. 
Endocytosis proceeds at 15-18°C, whereas phagocytosis does not occur at these 
temperatures. 
The respiratory burst is another important feature of phagocytosis (Babior, 1992). 
Internalization of a particle via the Fc receptor, or the mannose/fucose (MFR) receptor, 
triggers the formation of reactive oxygen intermediates (ROI), reactive nitrogen 
intermediates (RNI), as well as arachidonate and eicosinoid generation (Wright, 1983). 
Phagocytosis via he complement receptor, however, is not associated with oxidative 
activity (Wright, 1983). 
C) Comparison of Conventional and Unconventional Routes of Cell Entry: 
Implications for Evasion of Death 
Parasites may exploit "conventional" uptake processes in order to gain access to the 
intracellular environment. The entry of Salmonella typhimurium into epithelial cells, for 
example, may be linked to the phosphorylation of the EGF receptor (Galan, 1992). 
Transcytosis is exploited by some gonococci in crossing the columnar epithelium of the 
human fallopian tube mucosa (McGee, 1988). The drawback of this strategy, however, is 
that, should the host cell be a phagocyte, entry may trigger oxidative attack. Parasites may 
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defend themselves against oxidative attack through the production of enzymes which 
disable free radicals, such as catalase and superoxide dismutase (reviewed in James, 1991). 
Instead, however, many avoid this problem through the use of another phagocytic receptor, 
the complement receptor, which is not associated with a respiratory burst. 
Another problem associated with the use of conventional uptake processes by 
intracellular parasites is that the organism may be passed into a degradative pathway. For 
some organisms, such as S. typhimurium and the Leishmania species which are 
internalized by phagocytosis, survival in the acidic phagolysosome is not problematic; it is, 
in fact, preferred. Most intracellular parasites, however, are apparently adapted to avoid 
contact with lysosomal contents. 
The development of a parasite-driven mechanism of cell entry may confer an 
advantage on an intracellular parasites for a number of reasons. Firstly, it may simply be 
necessary for cell entry as some non-phagocytic cells lack the proper uptake apparatus 
which would allow the entry of the organisms. A parasite-driven strategy for cell entry 
may also provide a means by which the entering organism can avoid contact with the 
hostile environment of the lysosome. 
The strategy used by Trypanosoma cruzi to enter cells is a special case. The 
infectious form of this parasite, the trypomastigote, enters cells in an active process. 
Unlike the epimastigote, which appears to be taken up by a cytochalasin B-inhibited 
process (i.e. phagocytosis) (Zingales, 1985), trypomastigotes can enter both phagocytic 
and non-phagocytic cells (Vickerman, 1985; Zingales, 1985). Trypomastigotes enter host 
cells in an active process which, ironically, involves the recruitment of lysosomes to the 
site of invasions. In this process, the parasite is exposed to the hydrolytic, lysosomal 
enzymes (de Titto, 1983). The lysosomes fuse to form the membrane which eventually 
envelops the incoming parasite. (Tardieux, 1992). Although T. cruzi is able to withstand 
exposure to the lysosomal environment for some time, it must, however, escape from this 
compartment into the cytoplasm. Trypomastigotes which are able to exit the lysosomal 
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compartment survive intracellularly, whereas epimastigotes, which remain behind, are 
killed (Vickerman, 1985). 
Coccidian parasites, such as those of the genus Plasmodium, and T. gondii, also 
enter cells in an active process involving mobilization of the parasites' own cytoskeletal 
apparatus. Additional support for the theory that invasion by these organisms is, at least in 
part, a parasite-driven process includes the great speed at which these organisms enter 
cells. Invasion is complete in 5-10 seconds, an order of magnitude greater than 
phagocytosis (Silverstein,1993). The compartments in which these organisms reside, the 
parasitophorous vacuoles (PV), have also been found to neither acidify nor fuse with 
lysosomes or other compartments in the endocytic cascade (Ward, 1993; Bannister, 1990; 
Moulder, 1985; Joiner, 1990; Jones, 1972a & b; Sibley, 1985). It is this fusion- 
incompetence of the parasitophorous vacuole, particularly in T. gondii, that has aroused 
interest in how the membranes of these vacuoles may differ from the membranes of 
vacuoles formed in other uptake processes and the role these differences might play in 
intracellular survival. Recent work has shown that the vacuolar membrane surrounding T. 
gondii is modified by parasite-derived proteins which may contribute to the function of this 
membrane. As one of the goals of the work described in this thesis is to understand how 
the vacuolar membrane surrounding T. gondii is modified by one of these proteins - 
GRA3- a more detailed description of T. gondii is appropriate: 
D) Toxoplasma gondii: life cycle 
Toxoplasma gondii, responsible for the disease toxoplasmosis, is an 
apicocomplexan parasite. As is characteristic of the organisms belonging to this phylum, 
T. gondii has a complex of secretory organelles at its apical end. These organelles, include 
the rhoptries, the micronemes, and the dense granules, which are thought to play a role in 
invasion and intracellular survival. T. gondii is capable of invading a variety of nucleated 
cell types in both mammals and birds. Although three forms of the parasite exist, the 
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oocysts and tissue cysts are usually responsible for infections in humans (see figure below) 
The oocyst, containing the zygote form of the parasite, is shed only by felids. After 
passing through the animal's intestinal tract into the environment, the parasite sporulates, at 
which time it becomes infectious. Tissue cysts, which contain the slowly dividing 
bradyzoites, are usually encountered in raw or undercooked mutton, pork, or beef. 
Tachyzoites (trophozoites) are the actively replicating form of the parasite responsible for 
spread between cells and transplacental infection. 
JOCYSTS 
4 FECES 
INTERMEDIATE HOSTS 
Life cycle of Toxoplasma gondii (Markell, 1992) 
F) Toxoplasma gondii: clinical disease 
Primary infection with T. gondii in the immunocompetent host is usually 
asymptomatic. Primary infection may rarely result in a flu-like syndrome. In 
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immunocompromised hosts and the congenitally infected infants, primary infection may 
lead to life-threatening disease. Through the actions of an intact immune system, however, 
the primary infection is self-limited as tachyzoites are forced to retreat into intracellular 
cysts. If the immune system is unable to control the primary infection, the tachyzoites will 
continue to infect other cells and result ultimately in serious sequelae such as chorioretinitis, 
myocarditis and fatal encephalitis. Once cysts have formed, the host is at life-long risk for 
opportunistic reactivation of the parasite should immunosurveillance fail. 
The tissue cyst is the hallmark of latent infection. Until recently reactivation had 
not been a common medical problem outside the setting of Hodgkin’s disease. With the 
development of more powerful immunosuppressive therapies and the growing problem of 
the acquired immunodeficiency syndrome (AIDS), however, disease resulting from 
recrudescence of T. gondii has become more commonly encountered. Current medical 
therapy is effective against the actively replicating tachyzoite form of the parasite only. 
Given the growing problem of reactivation toxoplasmosis, future investigations will look at 
ways of attacking the encysted bradyzoite. 
G) Intracellular infection with Toxoplasma gondii 
The tachyzoite can replicate or only inside a host cell. It enters in an active process 
(appendix A) involving the formation of a specialized, membrane-bound compartment, the 
parasitophorous vacuole (PV). Parasite uptake is thought to be induced by the rhoptries, a 
gland-like member of the set of apical organelles, whose activities are limited to the time of 
invasion (Kimata, 1987; Porchet-Hennere 1983; Schwartzman, 1986; and Perkins, 1992). 
The PV neither acidifies nor fuses with lysosomes at any time after invasion (Joiner, 1990; 
Jones, 1972a & b; Sibley, 1985). The membrane of this vacuole, the parasitophorous 
vacuole membrane (PVM), is devoid of host cell proteins upon entry (Joiner, 1990). It is 
believed that this absence of proteins in the PVM is responsible for the vacuole's fusion- 
incompetence (Joiner, 1990). 

Once T. gondii has established residence in the host cell, the dense granules, 
another member of the set of apical organelles, release their contents (Charif, 1990; 
Leriche, 1991; Sibley, 1988). Secretion by the dense granules is followed by the 
formation of a tuboreticular network in the vacuolar space and the new appearance of 
intramembranous particles in the PVM (Porchet-Hennere, 1983). GRAS, one of five 
known dense granule proteins, is the major protein associated with the PVM. It is 
observed in increasing amounts as the vacuole matures (Dubremetz, 1993). 
Transport across membranes requires the presence of membrane-associated 
proteins. In order to survive intracellularly for long periods of time, T. gondii must be 
able to interact with the host cell to obtain nutrients. Modification of the protein-deficient 
PVM is necessary to allow the parasite's long-term intracellular survival. GRA3 is thought 
to play a central role in the modification of the PVM and T. gondii's long-term adaptation to 
intracellular life (Dubremetz, 1993; Ossorio, 1994; Joiner, 1994). I propose that the 
construction of a genomic clone of GRA3 provides the opportunity to further investigate 
the role of GRA3 in the intracellular survival of T. gondii as well as the protein's 
association with the PVM. 
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Experimental Methods and Design 
Genomic library 
A genomic library of Toxoplasma gondii inserted in the Eco RI site of A,—DASH II will be 
provided by David Roos, University of Pennsylvania. 
Bacterial hosts 
E. coli strain NM539 will be used as the host for the A.-DASH n vector. E. coli strain 
DH5a will be used as the host for the plasmid vector. 
Plasmid vector 
Bluescript (from Stratagene) will be used for transfection of DH5a and T. gondii. 
Epitope tag 
Oligonucleotide (c-myc) constructed at the Boyer center will be used (sequence = 5' - CGA 
GCA GAA GCT TAT CTC GGA GGA GGA TCT GAT - 3'; 5’ - CGA TCA GAT CCT 
CCT CCG AGA TAA GCT TCT GCT - 3’). 
Parasites 
T. gondii of the RH strain will be harvested from the peritoneum of Balb/C mice. 
ATTEMPTED CONSTRUCTION OF A cDNA CLONE 
1) PREPARATION OF THE TUBULIN PROMOTER FOR INSERTION INTO 18-3(4) 
The tubulin promoter was obtained from the tub/CAT plasmid through digestion 
with NSI [5 pi plasmid, 1 pi NSI, 1 pi NSI buffer, 3 pi d H2O] at 37°C for 2 hours. The 
promoter was gel purified and collected through ‘freeze and squeeze.’ DNA was 
precipitated according the the phenol/chloroform (P/C) protocol (described below). The 
promoter was then Klenowed [7.5 pi promoter DNA, 0.5 pi dNTPs (2.5 mM), 1 pi ligase 
buffer, 1 pi Klenow enzyme] at room temperature for 1/2 hour. 
2) PREPARATION OF 18-3(4) FOR INSERTION OF THE TUBULIN PROMOTER 
The native Cla I site was removed from 18-3(4), a Bluescript plasmid containing 
GRA3 at the Eco RI site, through digestion at the Xho I and Eco RV sites [1.5 pi plasmid. 
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1 Hi Xho, 1 Hi Eco RV, 2 Hi buffer, 2 h1 BSA, 12.5 Hi dH20] at 37°C for 1 hour. IhI 
Klenow enzyme and IhI dNTPs was added to the tube and the reaction allows to run at 
room temperature for 1/2 hour. The linearized plasmid was gel purified and eluted using 
the GeneClean™ Kit 
31 INSERTION OF THE TUBULIN PROMOTER INTO 18-3(41 AND SCREENING 
A) Ligation of plasmid and insert 
Ligation reactions (16°C for 4 hours) were done using plasmid insert ratios of 1:1 
and 1:3. DNA from each tube was isolated using the P/C protocol and resuspended in 10 
pi of sterile water. For each reaction, 2 h1 of DNA was added to an aliquot tube to which 
40 pi of E. coli DH5a was added. Each sample was electroporated (2.5 volts, 25 
amperes, 200 ohms). After electroporation, 800 Hi of SOC media was added to each tube 
and the tubes were incubated at 37°C for 1 hour. Bacteria were innoculated in 
concentrations of 20 Hi and 200 pi on LB + ampicillin (100 pg/ml) plates and incubated for 
16 hours at 37 °C. 
A) Screening for positive transformants 
Plates were screened for the presence of the promoter using the colony lift 
technique (described below). A plasmid prep (Sambrook, 1989) was performed on alleged 
positive transformants. DNA was cut with Cla I to determine the number of Cla I sites [1 
pi plasmid, 1 pi Cla I, 1 pi buffer, 1 pi BSA, 6 pi dH20] at 37° C for 1 then run on a gel. 
A separate was then run to confirm the presence of the promoter [ 1 pi plasmid, 1 pi Kpn I, 
1 pi Sac I, 2 pi buffer, 2 pi BSA, 13 pi dH201 at 37 °C for 1 hour and then run on a gel. 
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PROPOSED CONSTRUCTION OF A GENOMIC CLONE 
D ISOLATION OF A GENOMIC CLONE OF GRA3 FROM THE X-DASH II LIBRARY 
A) Screening of genomic libraries with a radioactive probe 
il Preparation of plating culture 
50 ml of sterile LB medium supplemented with 0.2% maltose will be placed in a 
sterile flask and inoculated with a single bacterial colony of E. coli NM539. The culture 
will be grown overnight at 37°C with agitation of 250 cycles/minute. The cells will be 
centrifuged at 4000 g for 10 minutes at room temperature. The supernatant will be 
discarded and the pellet resuspended by vortexing in approximately 20 ml sterile 0.01M 
MgS04. 
ii) Calculating the number of colonies required for screening 
The number of colonies to be screened was determined to be 1.8 x 10 4 given a 
genome size of 80 megab (Sibley, 1993) and an insert size of 20 kb for X-DASH. 10 90- 
mm plates will be innoculated and screened. 
iii) Plating of the genomic library 
Into one sterile tubes (13 mm x 100 mm; one tube per plate), a mixture containing 
0.1 ml of the plating bacteria (E. coli NM539) with 0.1 ml of SM [ 5.8 g NaCl, 2 g 
MgS04 7 H2O, 50 ml 1M Tris Cl (pH 7.5), 5 ml 2% gelatin solution, H2O to 1 liter] 
containing 3 x 10^ pfu (90-mm plates) of the bacteriophage X-DASH library will be 
placed. The infected bacteria will be incubated for 20 minutes at 37°C. To each tube 2.5 
ml of molten top agarose will be added and the mixture immediately poured onto a dry LB 
agar plate. The infected plates will be incubated for 3.5 hours at 42°C. (Sambrook, 1989) 
1 5 

iv) Transfer to filters 
Nitrocellulose filters (NCF) will be overlaid on plates allowing 20 minutes for 
plaque absorption. Filters and agar will be marked with 18-gauge needle before removal of 
the filter. Special care will be taken to leave top agarose intact upon removal of the filter. 
Filters (plaque side up) will be dried at room temperature for 20 minutes (will do duplicate 
lift for control). Filters will be dipped sequentially for 30-60 seconds into 100 ml of the 
following three solutions: a) 0.2 M NaOH, 1.5 M NaCl, b) 2x SSC, 0.4 M Tris, pH 7.4, 
c) 2x SSC. Filters will be dried for 1 hour at room temperature on Whatman 3MM paper, 
then in a vacuum oven for 2 hours at 80°C. 
v) Prehvbridization 
Filters will be placed in a heat-sealable plastic bag to which 10 ml of hybridization 
buffer S [3 ml 10% PVP (polyvinylpyrrolidone), 3 ml 10% BSA, 3 ml 10% Ficoll 400, 
2.2 ml salmon sperm DNA stock (10 mg/ml), 15 ml 20 x SSC buffer stock, 250 mg yeast 
RNA, ILO 10 150 ml] will be added. The bag will be incubated at room temperature for 
2-3 hours. 
vi) Labeling of synthetic cDNA probe 
Boehringer Mannheim Biochemica labeling kit will be used. cDNA GRA3 probe (2 
jil) will be added to 9 (il of dH20 in a microfuge tube. Probe will be denatured by heating 
for 10 minutes at 100°C and then cooled on ice. The following will be added to the 
microfuge tube: 1 jil each of dATP, dGTP, and dTTP; 2 (il reaction mixture (from kit), 3 
|il 50 p.Ci [a32p] dCTP, and 1 p.1 Klenow enzyme. The contents of the tube will be 
incubated at 37°C for 1 hour. 2 jil of 0.2M EDTA will be added to the above to stop the 
reaction. 

vii) Hybridization to filters and Primary Screen 
32p.labeled probe will be added to 10 ml of buffer and the mixture will be added to 
the bag. After the bag is sealed it will be incubated overnight at 65°C. The next day, the 
filters will be placed in plastic dishes for washing under the following conditions: i) 2x 
SSC/.1% SDS at room temperature for 20 minutes, ii) .2x SSC/.1% SDS at room 
temperature for 20 minutes, and iii) .2x SSC/.1% SDS at 65°C for 20 minutes. Filters will 
be incubated for an additional 30 minutes after changing the buffer and reducing the 
temperature to 55°C. Filters will be blotted between two pieces of of Whatman 3MM filter 
paper and air-dried for 30 minutes. Filters will be mounted on Whatman 3MM filter paper 
and covered with clear plastic wrap. Luminescent tape will be used for orientation and 
autoradiography will be performed overnight at -70°C with screen and X-ray film. The film 
will be developed the next day. 
viii) Secondary Screen 
200 fj.1 of NM539 E. coli will be aliquoted into a 13 x 100 mm tube. 2.5 ml of LB 
top agar with 10 mM MgSC>4 at 48°C will be added and poured immediately into a 90-mm 
LB agar plate at room temperature and left to settle for 5 minutes. Each plate will be labeled 
with a grid with room for 50 secondary plaques. Film will be aligned with luminescent 
tape markers over filters marking the position of the filters' positioning holes on film. 
Plaques with a corresponding positive autoradiographic signal on the library plates will be 
transferred to individual squares on grid of bacterial lawn by gently puncturing lawn with 
toothpick. Plate will be incubated overnight at 37°C. Filters will be lifted and screened as 
described above. 
ix) Tertiary screen 
Phage from a single hybridizing secondary plaque generated by each primary signal 
will be transferred with a toothpick for each positive primary signal. Toothpicks will be 

dropped into 10 ml of sterile TMG buffer [10 mM Tris, pH 7.4 0.5 ml of 2M stock, 10 
mM MgS04 1 ml of 1M stock, 0.01% gelatin 10 mg, add H2O to 100 ml] in a sterile tube. 
The mixture will be mixed gently by hand to disperse phage. 0.25 and 2.5 pi TMG 
mixture will be placed into two sterile 13 x 100 mm tubes containing 200 pi of NM539 
plating cells. 2.5 ml of LB top agar with 10 mM MgSCLj. at 48°C will be immediately 
poured over LB agar 90-mm plate at room temperature and allowed to harden for 15 
minutes at room temperature. Plates will be incubated for 4 hours at 37°C. Tertiary grids 
will be hybridized and screened , as above. Positive signals are plaque purified clones. 
One positive from a primary positive will be transferred with a toothpick to 5 ml of TMG 
buffer, as above. 1 pi of TMG mix will be added to 200 pi of NM539 plating cells and 
plated as above. Plates will be incubate for 4 hours at 37°C. 
B) Preparation and purification of DNA from bacteriophage 
i) preparation of 10 ml Lvsate 
10 ml of LB medium supplemented with MgS04 (10 mM final) will be added to a 
50-ml capped, sterile tube. An agar plug containing a single plaque will be transferred to 
the tube with a sterile pipette. 50 pi of NM539 plating cells will be added to tubes which 
will then be put in a shaker (vigorous setting) with good aeration for 6-12 hours. Culture 
should become cloudy and then clear with lysis. After lysis, 100 pi of chloroform will be 
added to tube which will be shaken for an additional 2 minutes at 37°C. The tube will be 
spun for 10 minutes at 3,000 x g at room temperature to remove bacterial debris. Upper 
aqueous phase will be removed and placed in a new tube. 100 pi of sterile 1 M MgS04 
solution will be added to each 10 ml of lysate. 
ii) Tittering and plating of the 10 ml lysate of phage 
A single colony of E. coli NM539 will be inoculated into 50 ml sterile LB medium 
with 20% maltose. Cells will be grown to an O.D. of 0.5 at 600 nm and collected by 

centrifugation for 10 minutes at 3,000 x g. The pellet will be resuspended in 25 ml of 
sterile 10 mM MgS04. A series of 10-fold dilutions of 1 pi of phage in TMG buffer will 
be made in microfuge tubes. 1 pi of diluted phage will be added to a sterile 12 x 75 mm 
culture tube. 200 pi of plating bacteria and 2.5 ml of top agar (cooled to 48-50°C) will be 
added to each culture tube. The mixture will then be immediately poured over bottom agar 
(37°C) on a 90-mm plate marked in a grid pattern. After top agar has hardened for 15 
minutes, plates will be incubated at 37°C for 4 hours. 
iii) DNA preparation of 10 ml Lvsate solution: Isolation of DNA 
10 ml of TM buffer and 320 pi of fresh DNAase I will be added to 10 ml of lysate 
and incubated for 15 minutes on ice after gentle mixing. 2 ml of 5 M NaCl and 2.2 g of 
solid PEG-6000 will be added (PEG must be completely dissolved). Mixture will be 
incubated on ice for 15 minutes and then spun for 10 minutes at 12,000 x g at 4°C. 
Supernatant will be discarded and pellet resuspended in 300 pi of TM buffer. After 
transfer of resuspended pellet to 1.5-ml microfuge tube, 300 pi of chloroform will be 
added. Phases will be separated through spinning for 5 minutes. Upper aqueous phase 
will be transferred to a new tube. Chloroform extraction will be repeated once more. 15pl 
of 0.5 M EDTA, pH 8.0, 30 pi of 5 M NaCl and 359 pi SS-phenol (salt -saturated 
phenol; Davis, 1986) will be added to the aqueous phase. After vortexing the tube will be 
microcentrifuged for 5 minutes. Extraction will be repeated with 350 pi of chloroform. 
DNA will be precipitated in 875 pi ethanol added to the aqueous phase. Tube will be 
placed on ice for 10 minutes then microcentrifuged for 5 minutes at 4°C. Supernatant will 
be discarded and DNA resuspended in 80% ethanol. Tube will be microcentrifuged for 2 
minutes at 4°C. Ethanol will be discarded and DNA dried in vacuum. DNA will be 
resuspend in 50 pi of TE buffer (Davis, 1986). 
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C) Detection and orientation of GRA3 gene and promoter 
The phage and vector will be digested with Bam HI, Eco RI, Eco RV, Hind I, Sac 
I, and Sal I. Fragments will be analyzed in a Southern blot analysis with hybridization as 
described in Davis for localization of GRA3 (Davis, 1986). GRA3 will be obtained 
through analysis of the Southern blot and gel purification. 
To determine the presence of the promoter in the insert, the smaller fragment 
obtained after digestion of fragment containing GRA3 with Bam HI and gel purification 
will be inserted (upstream) into a plasmid containing the chloramphenicol acetyltransferase 
(CAT) gene. A functional analysis, as described in Soldati, will be performed (Soldati, 
1993). Should the genomic promoter be absent, a tubulin promoter will be used in its 
place. 
D) Subcloning of plaque purified genomic GRA3 into plasmid vector 
GRA3 and genomic promoter isolated from the 7.-DASH library will be 
precipitated according to the phenol/chloroform extraction (P/C) (Davis, 1986). A Cla I 
minus Bluescript plasmid will be digested with Eco RI for 1 hour. P/C will be repeated for 
both insert and plasmid. Linearized plasmid will be dephosphorylated with calf intestinal 
phosphatase (CLP) according to the Sambrook protocol 1.60 to prevent self ligation 
(Sambrook, 1989). Two ligation reactions (16° C for 4 hours) will be done using a 
plasmid-to-insert ratios of 1:1 and 1:3. DNA will be isolated using P/C and suspended in 
10 jj.1 sterile water. 2 pi of the ligated plasmid for each reaction will be placed in separate 
aliquot tube to which 40 pi E. coli DH5a will be added. Each sample will be 
electroporated (2.5 volts, 25 amperes, 200 ohms). After electroporation , 800 pi of SOC 
media will be added to each tube and each will be incubated at 37°C for 1 hour. Bacteria 
will be plated on LB + ampicillin (100 pg/ml) plates , each batch in concentrations of 20 pi 
and 200 pi and incubated at 37°C for 16 hours. 16 colonies will be selected for plasmid 
prep (Sambrook, 1989). 
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To establish the uniqueness of the Cla I site, the constructed plasmid will be 
digested will Cla I for 1 hour and screened through gel electrophoresis. 
ID Insertion of the epitope tag 
Plasmid carrying genomic GRA3 will be cut will Cla I for 1 hour then precipitated 
according to the phenol/chloroform protocol. The linearized plasmid will be Klenowed and 
then dephosphorylated as described by Sambrook 1.60 (Sambrook, 1989). Two ligation 
reactions (16° C for 4 hours) using plasmid and the c-myc epitope to be inserted will be set 
up with a plasmid-to-insert ratio of 1:1 and 1:3. DNA will be isolated using P/C and 
suspended in 10 (_il sterile water. 2 |il of the ligated plasmid will be placed in an aliquot 
tube (1 tube per batch) to which 40 pi E coli DH5a will be added. Each sample will be 
electroporated (2.5 volts, 25 amperes, 200 ohms) aiming for a time constant of 4.8. After 
electroporation, 800 pi of SOC media will be added to each tube and each will be incubated 
at 37°C for 1 hour. Bacteria will be plated on LB + ampicillin (100 pg/ml) plates, each 
batch in concentrations of 20 pi and 200 pi. and incubated at 37°C for 16 hours. 
Orientation of the epitope will be determined via sequencing. 
HI) Transfection of Toxoplasma bv electroporation (Kim, 1993) 
10-50 pg of plasmid linearized will be electroporated into 10 ^ to 5 x 10^ freshly 
lysed tachyzoites of the RH strain in Cytomix (van den Hoff, 1992). The parasites will be 
used to infect human foreskin fibroblasts (HFF). Expression of the clone will be 
determined using a fluorochrome-labeled anti-c-myc IgG in a direct immunofluorescence 
analysis. 

Outline of experimental design for construction of a genomic clone 
I. Isolation of the genomic clone from the X-DASH n (41,900 bp) library 
A. Screening of genomic libraries with a radioactive probe 
>.-DASH II with genomic insert: 
left end 0 Sal I Eco RI 20 kbp insert 
=SrJ==L"GRA3" 
Eco RI Sal I 
I I 
i) Preparation of plating culture 
ii) Calculating the number of colonies required for screening 
iii) Plating of the genomic library 
iv) Transfer to filters 
v) Prehybridization 
vi) Labeling of synthetic cDNA probe 
vii) Hybridization to filters and Primary Screen 
viii) Secondary Screen 
ix) Tertiary Screen 
B. Preparation and purification DNA from bacteriophage 
i) Preparation of 10 ml Lysate 
ii) Tittering and plating of 10 ml Lysate 
iii) DNA preparation of 10 ml Lysate solution: Isolation of DNA 
C. Detection and orientation of GRA3 gene and promoter 
digest with Eco RI, Eco RV, Sal I, Sac I, Bam HI, and Hind I 
Southern blot analysis and hybridization 
functional assay to detect promoter 
D. Subcloning of plaque purified genomic GRA3 into plasmid vector 
Isolated fragment of GRA3 and promoter: 
500 bp 1868bp 
I I I 
P GRA3 
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P/C; Klenow; P/C 
Bluescript: 
Eco Rl 0 
501 
1900 
Remove Cla I site: Klenow; ligate: 
Xho 2221 
Eco Rl 0 
2961 bp 
I 900 
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Ligate insert and plasmid: 
promoter 
Transfect bacteria; pick colonies; prepare DNA; digest with Cla I to detect 
added Cla I sites 
II. insertion of the epitope tag 
digest with Cla I; Klenow; dephosphorylate; ligate: 
promoter 
sequence 
HI. Transfection of Toxoplasma by electroporation 
infect tissue culture; immunofluorescence 
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Results 
No experiments to isolate a genomic clone have yet been conducted. Previous 
attempts to construct a plasmid containing an epitope-tagged version of GRA3 cDNA have 
were unsuccessful and are summarized here. Based on the lack of success of this system, 
and the desire to isolate genomic clones for subsequent knock-outs of GRA3, the decision 
was made to focus on isolation of GRA3 genomic clones. Construction of a plasmid (from 
Bluescript) carrying a copy of cDNA for GRA3 at the Eco RI site, and the tubulin promoter 
(500 bp) between the Xho I and Eco RV sites was attempted. Insertion of the tubulin 
promoter was not accomplished most probably secondary to technical problems. 
Ligation reactions were set up and, DH5a bacteria were transfected, as described 
above. Selection for transformants was performed plating electroporated bacteria on LB+ 
amp plates overnight at 37°C. Although the yield was never high, some colonies did 
appear on the plates. The plates were screened using the colony lift technique (described 
above) which, again, indicated that there were positive transformants. A plasmid prep was 
performed on these alleged transformants. The plasmids were cut with Cla I to and they 
linearized (see Appendix B: photo 19/25/93) as would have been expected given the 
removal of the Cla I site in the Xho I to Eco RV segment. To screen for the presence of 
actual transformants v. reannealed plasmids with the Cla I site removed, cutting with Kpn I 
and Sac I was performed to determine the size of the segments and thus detect the presence 
of the promoter (see diagram). No 977 bp segment was seen on gel purification (see 
Appendix B: photo II 9/25/93) indicating that although the plates and the filters screened 
positive, there were no transformants carrying the promoter. These false positive results 
could be attributed to transformation of the bacteria by reannealed plasmid not containing 
the promoter. It is possible that the filters used on colony lift were either not washed 
sufficiently or that the plasmid contains a sequence with enough homology to the promoter 
that it can partially hybridize to it. 
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Outline of attempted construction of plasmid containing cDNA of GRA3 
Bluescript plasmid containing indigenous Cla I site and GRA3: 
Excise Xho I-Eco RV segment to remove indigenous Cla I site. 
Ligate tubulin promoter and plasmid: 
4636 bp 
Cut with Cla I: Does plasmid linearize? 
Cut with Kpn I and Sac I: Do three fragments appear? 
Kpn I 
i_nn 
Sac I Sac I 
]—|-"1 I-\— 
Sac 1 
1 
SacI L 
p GRA3 GRA3 
977 bp 1300bp 2208bp 
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Discussion 
A) Significance of GRA3: How proteins cross membranes 
Construction of a genomic clone of GRA3 for electroporation into T. gondii creates 
the opportunity to do two things. First, it provides an opportunity to do knockout 
experiments. Second, it may also provide the opportunity to look at the topology of the 
protein in the membrane. GRA3's function with respect to the intracellular survival of T. 
gondii remains a mystery. It is thought, however, that given the appearance and 
association of the protein with the PVM sometime after invasion that perhaps this protein 
plays a role in the transport of nutrients from the host cell to the parasite. 
The mechanisms used by small molecules to cross membranes are quite different 
from those used by particles and parasites to enter cells; vesicle formation is unnecessary. 
Pure lipid membranes are impermeable to water-soluble molecules. Thus the transport of 
small molecules into the cytosol takes place in processes, including passive diffusion, 
facilitated diffusion, and active transport, which all depend on the presence of specialized 
membrane-associated proteins. The function of a membrane-associated protein can, in 
part, be predicted by the topology of that protein with respect to the membrane. 
Understanding the nature of GRA3's relationship with the PVM could potentially uncover 
the role it may play in the parasite's survival. 
B) Mechanisms of protein association with membranes 
To understand how GRA3 may associate with the PVM, it is necessary to 
characterize the membrane-protein interaction. There are essentially two known classes of 
membrane-associated proteins. Integral membrane proteins (IMP) associate through 
interactions with hydrophobic domains in the lipid bilayer. In contrast, peripheral 
membrane proteins (PMP) associate with the membrane through ionic interactions with 
either integral membrane proteins or directly with the polar heads of the lipids in the 
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bilayer. These proteins can be distinguished from integral membrane proteins through 
extraction procedures which disrupt the ionic bonds. 
Transmembrane proteins are a class of integral membrane proteins which 
completely cross the lipid bilayer. The Lenard & Singer model (Singer, 1990) predicts that 
all transmembrane proteins are amphipathic, having a required hydrophobic region able to 
span the membrane, as well as a hydrophilic region able to exist in both the extracellular 
and cytoplasmic environments. It is thought that the hydrophobic sequence crosses the 
membrane as an alpha helix containing at least 15 hydrophobic amino acid residues 
(Singer, 1990). The photoreaction center in the membranes of photosynthetic bacteria is 
the only integral membrane protein for which this structure has been physically confirmed 
(Singer, 1990). 
Singer describes four types of transmembrane proteins. Types I and II span the 
membrane only once, however, they differ as to whether the NH2 terminus is oriented 
inside or outside of the cell. Type HI, or polytopic proteins, have more than one 
hydrophobic region which crosses the membrane. The channel forming proteins form 
class IV. This class is divided into proteins that form polymers before or during insertion 
into the membrane and those which cross as a single folded protein. 
As mentioned earlier, some proteins lack adequate hydrophobic residues to directly 
insert into a membrane. In such cases co- or post-translational modification can play an 
important role in the protein's association with the membrane. In their 1993 review of 
chemical modification of proteins in vivo, Reicker and McGee stated that peptide bond 
cleavage and formation, modification of the amino or carboxyl terminal amino acids, and 
modification of specific amino acid side-chain moieties as the three major types of protein 
modification. Of those mentioned, modification of a terminal amino acid or a side chain 
through the attachment of a lipid, a process known as acylation, could facilitate a protein's 
association with the hydrophobic portion of the membrane. 
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Prenylation, is a category of acylation in which a specific group of lipids, the 
isoprenoids, are added to proteins. This process is currently being studied with respect to 
its involvement in the membrane targeting and transformative properties of the Ras protein 
(Brown, 1993; Chow, 1992; Travis, 1993; Marshall, 1993) Present data suggest that one 
of two possible isoprenoids, a 15-carbon famesyl or a 20-carbon geranylgeranyl, must be 
added to the Ras protein in order for it to be targeted to the membrane and cause 
transformation of the cell. The signal for famesyl addition appears to be a CAAX box 
which is a terminal cysteine, with 2 aliphatic or linear amino acids, including either serine, 
methionine, or glutamine. Addition of the geranylgeranyl requires a CAAX ending in 
leucine or motifs CC or CXC. As will be explained below, GRA3 does not qualify for 
prenylation. 
Glycosylphosphatidylinositol (GPI)-linkage is another mechanism by which 
proteins associate with membranes. GPI is added to the c-terminus of proteins in the 
endoplasmic reticulum at six possible sites, ser, glu, ala, sys, asp, or asn. These linkages 
can be disrupted by phospholipase C. GP-2, the major GPI-linked glycoprotein of 
pancreas zymogen granule membranes, and Tamm-Horsfall protein (THP), a GPI-linked 
protein associated with the apical vesicles in kidney thick ascending limb of loop of Henle 
cells (TALH) have been shown to compose a unique class of GPI-linked proteins which 
self-associate with membranes in a pH- and ion-dependent process (Fukuoka, 1992). 
Either mechanism of GPI-association is not likely to be involved in GRA3's association 
with the PVM as the protein is secreted in a soluble form which subsequently associates 
with the membrane. 
C) GRA3 and the parasitophorous vacuole membrane 
Given the above, what can we predict about the topology of GRA3 with respect to 
the PVM? Data exists which suggests that GRA3 is an integral membrane protein in the 
PVM (Ossorio, 1994). It is unclear, however, whether GRA3 is a transmembrane protein. 
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Although GRA3 does not have the 15-20 consecutive hydrophobic amino acids required to 
cross the plasma membrane, it has shorter hydrophobic regions that may allow it to interact 
with the membrane in some other way as well as several stretches of amphipathic helix 
(Bermudes, 1994). Another piece of data that suggests that GRA3 does not cross the 
plasma membrane was obtained in selective permeability studies. GRA3 was not detected 
on the cytoplasmic surface (Beckers, 1993 unpublished). This finding may reflect poor 
immunogenicity on the part of the epitope as the control also failed to label. In a study of 
parasite invasion, however, fluorescence to GRA3 was detected extending from the PVM 
into the host cell cytoplasm (Dubremetz, 1993) suggesting that the protein may in fact cross 
the membrane. 
Exploration of the possibility that GRA3 is a peripheral membrane protein has 
suggested that the protein is not. GRA3 does not form ionic bonds to either the membrane 
or other membrane proteins (Ossorio, 1994). GRA3 is not released from the membrane in 
extremes of pH or NaCC>3 in extraction studies (Ossorio, 1994). In recent experiments, 
GRA3 also failed to crosslink any protein other than itself (Ossorio, 1993). Limited 
conclusions can be drawn from these finding, as in the case of the crosslinking study, 
however, rhoptry protein 2-3, a known transmembrane protein, also failed to label well. 
GRA3's association with the PVM does not appear to be facilitated by the addition 
of a lipid moiety. Firstly, GRA3 does not label acetate studies (Ossorio, 1993). Nor 
does the protein does not meet the criteria (i.e. CAAX box, C-terminal hydrophobic 
stretch) for participation in a lipid anchoring process. 
GRA3 may be a pore forming protein. The PVM of T. gondii has been found to 
have a pore-like channel which allows free diffusion of small charged and uncharged 
particles (Schwab, 1993). Unlike C9 and perforin, however, which are also soluble 
proteins that polymerize and insert into membranes, this pore does not result in cell lysis. 
GRA3 appears to be secreted from dense granules as a soluble molecule which forms 
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